Cargando…
Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix
The Bcl-2 family of apoptotic regulators is thought to play an essential role in cancer development and influence the sensitivity of tumour cells to radiotherapy. Bid is an abundantly expressed Bcl-2 family protein playing a central role in various pathways of apoptosis by integrating and converging...
Autores principales: | Green, M M L, Hutchison, G J, Valentine, H R, Fitzmaurice, R J, Davidson, S E, Hunter, R D, Dive, C, West, C M L, Stratford, I J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362081/ https://www.ncbi.nlm.nih.gov/pubmed/15685241 http://dx.doi.org/10.1038/sj.bjc.6602344 |
Ejemplares similares
-
Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy
por: Sheridan, M T, et al.
Publicado: (2000) -
Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix.
por: West, C. M., et al.
Publicado: (1993) -
Proapoptotic protein Bid is regulated by phosphorylation during anoikis and the cell cycle
por: Lindsay, J, et al.
Publicado: (2008) -
Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.
por: Sproston, A. R., et al.
Publicado: (1995) -
No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix
por: Kabuubi, P, et al.
Publicado: (2006)